Biohaven Pharmaceutical Holding Co Ltd.

SCHRODER INVESTMENT MANAGEMENT GROUP

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

71,140

Value ($000)

10,754

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	10,754	0.0%	71,140	9/30/2022
2022 Q2	8/11/2022	10,026	0.0%	68,810	6/30/2022
2022 Q1	5/16/2022	7,946	0.0%	67,324	3/31/2022
2021 Q4	2/14/2022	6,199	0.0%	44,985	12/31/2021
2021 Q3	11/12/2021	9,007	0.0%	64,841	9/30/2021
2021 Q2	8/13/2021	7,205	0.0%	74,215	6/30/2021
2021 Q1	5/28/2021	3,686	0.0%	53,928	3/31/2021
2020 Q4	2/16/2021	3,825	0.0%	44,631	12/31/2020
2020 Q3	11/13/2020	3,358	0.0%	51,613	9/30/2020
2020 Q2	8/13/2020	3,455	0.0%	47,258	6/30/2020
2020 Q1	5/15/2020	770	0.0%	24,010	3/31/2020
2019 Q4	2/11/2020	1,657	0.0%	30,436	12/31/2019